Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 4:11:591.
doi: 10.3389/fendo.2020.00591. eCollection 2020.

Endothelial Dysfunction in Diabetic Retinopathy

Affiliations
Review

Endothelial Dysfunction in Diabetic Retinopathy

Fu Gui et al. Front Endocrinol (Lausanne). .

Abstract

Diabetic retinopathy (DR) is a diabetic complication which affects retinal function and results in severe loss of vision and relevant retinal diseases. Retinal vascular dysfunction caused by multifactors, such as advanced glycosylation end products and receptors, pro-inflammatory cytokines and chemokines, proliferator-activated receptor-γ disruption, growth factors, oxidative stress, and microRNA. These factors promote retinal endothelial dysfunction, which results in the development of DR. In this review, we summarize the contributors in the pathophysiology of DR for a better understanding of the molecular and cellular mechanism in the development of DR with a special emphasis on retinal endothelial dysfunction.

Keywords: diabetes; diabetic retinopathy; endothelial cells; endothelial dysfunction; signaling pathways.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A schematic model of interaction networks mediated by glycosylation end products (AGE) that contributes to blood retinal (BRB) leakage in diabetic retinopathy.
Figure 2
Figure 2
A schematic model of interaction networks mediated by proliferator-activated receptor-γ (PPARγ) disruption that contributes to blood retinal (BRB) leakage in diabetic retinopathy.
Figure 3
Figure 3
A schematic model of interaction networks mediated by inflammation that contributes to blood retinal barrier (BRB) leakage in diabetic retinopathy.
Figure 4
Figure 4
A schematic model of interaction networks mediated by miRNAs that contributes to blood retinal (BRB) leakage in diabetic retinopathy.

References

    1. Gaborit B, Julla JB, Besbes S, Proust M, Vincentelli C, Alos B, et al. Glucagon-like peptide 1 receptor agonists, diabetic retinopathy and angiogenesis: the angiosafe type 2 diabetes study. J Clin Endocrinol Metab. (2020) 105:dgz069. 10.1210/clinem/dgz069 - DOI - PubMed
    1. Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight. (2017) 2:e93751. 10.1172/jci.insight.93751 - DOI - PMC - PubMed
    1. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis. (2015) 2:17. 10.1186/s40662-015-0026-2 - DOI - PMC - PubMed
    1. Simo R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. (2018) 61:1902–12. 10.1007/s00125-018-4692-1 - DOI - PMC - PubMed
    1. Bandello F, Lattanzio R, Zucchiatti I, Del Turco C. Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol. (2013) 50:1–20. 10.1007/s00592-012-0449-3 - DOI - PubMed

MeSH terms